Literature DB >> 15478038

The role of the somatotropic system in cognition and other cerebral functions.

Wouter M Creyghton1, P Sytze van Dam, Hans P F Koppeschaar.   

Abstract

Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) receptors can be found in several areas of the brain. GH receptors are mainly found in the choroid plexus, thalamus, hypothalamus, pituitary, putamen, and hippocampus, whereas IGF-1 receptors are mainly concentrated in the hippocampus and parahippocampal areas. In early life, GH and IGF-1 have an important role in the development and differentiation of the central nervous system. In the more developed central nervous system, GH and IGF-1 are thought to have a variety of functions such as a neuroprotective function, an appetite increasing function, various cognitive functions, and perhaps a blood flow-regulating function. In GH-deficient children and adults, improvement of cognitive functions was observed after the administration of GH. Furthermore, specific cognitive functions in healthy older subjects may improve after increasing GH or IGF-1 levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15478038     DOI: 10.1055/s-2004-835375

Source DB:  PubMed          Journal:  Semin Vasc Med        ISSN: 1528-9648


  8 in total

1.  Psychiatric and neuropsychological changes in growth hormone-deficient patients after traumatic brain injury in response to growth hormone therapy.

Authors:  N P Maric; M Doknic; D Pavlovic; S Pekic; M Stojanovic; M Jasovic-Gasic; V Popovic
Journal:  J Endocrinol Invest       Date:  2010-05-17       Impact factor: 4.256

Review 2.  What are critical outcome measures for patients receiving pituitary replacement following brain injury?

Authors:  Sorin G Beca; Walter M High; Brent E Masel; Kurt A Mossberg; Randall J Urban
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

3.  A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humans.

Authors:  Johannes D Veldhuis; Martin Bidlingmaier; Joy Bailey; Dana Erickson; Paola Sandroni
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

4.  Improved Sleep Quality is Associated with Reductions in Depression and PTSD Arousal Symptoms and Increases in IGF-1 Concentrations.

Authors:  Heather L Rusch; Pedro Guardado; Tristin Baxter; Vincent Mysliwiec; Jessica M Gill
Journal:  J Clin Sleep Med       Date:  2015-06-15       Impact factor: 4.062

Review 5.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

6.  The GH/IGF-I Axis and Cognitive Changes across a 4-Year Period in Healthy Adults.

Authors:  Jan Berend Deijen; Lucia I Arwert; Madeleine L Drent
Journal:  ISRN Endocrinol       Date:  2011-04-03

7.  The effect and mechanism of growth hormone replacement on cognitive function in rats with traumatic brain injury.

Authors:  Hao Zhang; Mengqi Han; Xiaonian Zhang; Xinting Sun; Feng Ling
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

8.  Insulin-like growth factor-1 and insulin-like growth factor binding protein 3 and risk of postoperative cognitive dysfunction.

Authors:  Jue Jiang; Zhifeng Chen; Bing Liang; Jia Yan; Ying Zhang; Hong Jiang
Journal:  Springerplus       Date:  2015-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.